|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61M 5/315 | (2006.01) |
| A61M 5/31533 | (2013.01) | ||
| A61M 5/3155 | (2013.01) | ||
| A61M 5/31556 | (2013.01) | ||
| A61M 5/31565 | (2013.01) | ||
| A61M 5/31573 | (2013.01) | ||
| A61M 5/31545 | (2013.01) |
| (11) | Number of the document | 3432949 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17714132.2 |
| Date of filing the European patent application | 2017-03-17 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/022869 |
| Date | 2017-03-17 |
| (87) | Number | WO 2017/165207 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 201662313260 P | 2016-03-25 | US |
| (72) |
BYERLY, Roy H. , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | DETERMINATION OF A DOSE SET AND DELIVERED IN A MEDICATION DELIVERY DEVICE |
| DETERMINATION OF A DOSE SET AND DELIVERED IN A MEDICATION DELIVERY DEVICE |